We suggest that IAP should be used as part of routine monitoring in the ICU and that future studies examining variables predictive of ICU-mortality should include IAP and BMI.
The new challenge to enhance the probability of decreasing mortality rates should include a more appropriate definition of sepsis based on more specific criteria involving biomarker use and accurate patient phenotypes.
The author calls for vigilance against such studies and argues that war related surveillance-based mortality estimates should include measures of sensitivity and representativeness.
Future studies examining the mortality of CDI should include basic demographic data, reporting of mortality at seven days, 30 days and 90 days after the first diagnosis of the CDI, the use of exclusion criteria and acquisition definitions as recommended in the international literature.
A key conclusion from our study is that both heat intensity and heat wave duration are important risk factors for temperature-related mortality; future research should include both components.
A mortality-based indicator should include all-cause, in-and-out-of hospital deaths within a standardized follow-up period, e.g. 30 days.
Studies on the impact of rheumatic diseases should include mortality data as a complement to those regarding functional status, work capacity and overall quality of life [ 5].
Inclusion criteria were as follows: critical care meta-analyses involving randomized controlled trial; the end points should include mortality; at least one component trial had more than 100 subjects per arm on average.
Adjudicated events should include CV mortality, myocardial infarction (MI), and stroke and can include hospitalization for acute coronary syndrome, urgent revascularization procedures, and possibly other end points.
